Viewing Study NCT05725018


Ignite Creation Date: 2025-12-25 @ 5:04 AM
Ignite Modification Date: 2025-12-26 @ 4:06 AM
Study NCT ID: NCT05725018
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-27
First Post: 2023-01-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients
Sponsor: Abeona Therapeutics, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module